chr1-235380120-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003193.5(TBCE):c.71G>A(p.Arg24His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,611,860 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R24C) has been classified as Uncertain significance.
Frequency
Consequence
NM_003193.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBCE | NM_003193.5 | c.71G>A | p.Arg24His | missense_variant | 2/17 | ENST00000642610.2 | |
TBCE | NM_001287801.2 | c.71G>A | p.Arg24His | missense_variant | 2/18 | ||
TBCE | NM_001079515.3 | c.71G>A | p.Arg24His | missense_variant | 2/17 | ||
TBCE | NM_001287802.2 | c.-240G>A | 5_prime_UTR_variant | 2/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBCE | ENST00000642610.2 | c.71G>A | p.Arg24His | missense_variant | 2/17 | NM_003193.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151314Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251468Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135908
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1460426Hom.: 3 Cov.: 32 AF XY: 0.0000523 AC XY: 38AN XY: 726516
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151434Hom.: 0 Cov.: 31 AF XY: 0.0000541 AC XY: 4AN XY: 73944
ClinVar
Submissions by phenotype
Encephalopathy, progressive, with amyotrophy and optic atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 23, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Autosomal recessive Kenny-Caffey syndrome;C1855840:Hypoparathyroidism-retardation-dysmorphism syndrome;C4310667:Encephalopathy, progressive, with amyotrophy and optic atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 17, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 21, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 24 of the TBCE protein (p.Arg24His). This variant is present in population databases (rs766386026, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TBCE-related conditions. ClinVar contains an entry for this variant (Variation ID: 1033981). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at